Literature DB >> 33523448

Intestinal Regulatory T Cells.

Vanessa R Figliuolo da Paz1, Deepa R Jamwal1, Pawel R Kiela2,3.   

Abstract

Mucosal surfaces are distinctive sites exposed to environmental, dietary, and microbial antigens. Particularly in the gut, the host continuously actively adapts via complex interactions between the microbiota and dietary compounds and immune and other tissue cells. Regulatory T cells (Tregs) are critical for tuning the intestinal immune response to self- and non-self-antigens in the intestine. Its importance in intestinal homeostasis is illustrated by the onset of overt inflammation caused by deficiency in Treg generation, function, or stability in the gut. A substantial imbalance in Tregs has been observed in intestinal tissue during pathogenic conditions, when a tightly regulated and equilibrated system becomes dysregulated and leads to unimpeded and chronic immune responses. In this chapter, we compile and critically discuss the current knowledge on the key factors that promote Treg-mediated tolerance in the gut, such as those involved in intestinal Treg differentiation, specificity and suppressive function, and their immunophenotype during health and disease. We also discuss the current state of knowledge on Treg dysregulation in human intestine during pathological states such as inflammatory bowel disease (IBD), necrotizing enterocolitis (NEC), graft-versus-host disease (GVHD), and colorectal cancer (CRC), and how that knowledge is guiding development of Treg-targeted therapies to treat or prevent intestinal disorders.

Entities:  

Keywords:  Immune tolerance; Immunotherapy; Inflammation; Microbiota; Treg

Mesh:

Year:  2021        PMID: 33523448     DOI: 10.1007/978-981-15-6407-9_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  373 in total

Review 1.  Microbiota Manipulation With Prebiotics and Probiotics in Patients Undergoing Stem Cell Transplantation.

Authors:  Tessa M Andermann; Andrew Rezvani; Ami S Bhatt
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

2.  Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease.

Authors:  Johanna Sophie Alfen; Paola Larghi; Federica Facciotti; Nicola Gagliani; Roberto Bosotti; Moira Paroni; Stefano Maglie; Paola Gruarin; Chiara Maria Vasco; Valeria Ranzani; Cristina Frusteri; Andrea Iseppon; Monica Moro; Maria Cristina Crosti; Stefano Gatti; Massimiliano Pagani; Flavio Caprioli; Sergio Abrignani; Richard A Flavell; Jens Geginat
Journal:  J Allergy Clin Immunol       Date:  2018-01-31       Impact factor: 10.793

3.  [Distribution of enzyme activity in the epithelium of the oral cavity of rats].

Authors:  C Ayanoglou; D Septier
Journal:  Actual Odontostomatol (Paris)       Date:  1985-12

Review 4.  The Intestinal Epithelium: Central Coordinator of Mucosal Immunity.

Authors:  Joannie M Allaire; Shauna M Crowley; Hong T Law; Sun-Young Chang; Hyun-Jeong Ko; Bruce A Vallance
Journal:  Trends Immunol       Date:  2018-04-30       Impact factor: 16.687

5.  Low expression of CD39(+) /CD45RA(+) on regulatory T cells (Treg ) cells in type 1 diabetic children in contrast to high expression of CD101(+) /CD129(+) on Treg cells in children with coeliac disease.

Authors:  K Åkesson; A Tompa; A Rydén; M Faresjö
Journal:  Clin Exp Immunol       Date:  2015-04       Impact factor: 4.330

6.  Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers.

Authors:  Afonso R M Almeida; Nicolas Legrand; Martine Papiernik; António A Freitas
Journal:  J Immunol       Date:  2002-11-01       Impact factor: 5.422

7.  Oral lactoferrin to prevent nosocomial sepsis and necrotizing enterocolitis of premature neonates and effect on T-regulatory cells.

Authors:  Ilke Mungan Akin; Begum Atasay; Figen Dogu; Emel Okulu; Saadet Arsan; H Deniz Karatas; Aydan Ikinciogullari; Tomris Turmen
Journal:  Am J Perinatol       Date:  2014-05-16       Impact factor: 1.862

8.  Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

Authors:  Sarah E Allan; Sarah Q Crome; Natasha K Crellin; Laura Passerini; Theodore S Steiner; Rosa Bacchetta; Maria G Roncarolo; Megan K Levings
Journal:  Int Immunol       Date:  2007-02-27       Impact factor: 4.823

9.  An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.

Authors:  C Asseman; S Mauze; M W Leach; R L Coffman; F Powrie
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

10.  Faecalibacterium prausnitzii Skews Human DC to Prime IL10-Producing T Cells Through TLR2/6/JNK Signaling and IL-10, IL-27, CD39, and IDO-1 Induction.

Authors:  Joudy Alameddine; Emmanuelle Godefroy; Loukas Papargyris; Guillaume Sarrabayrouse; Julie Tabiasco; Chantal Bridonneau; Karina Yazdanbakhsh; Harry Sokol; Frédéric Altare; Francine Jotereau
Journal:  Front Immunol       Date:  2019-02-06       Impact factor: 7.561

View more
  1 in total

Review 1.  Extracellular Vesicles: The Next Generation Theranostic Nanomedicine for Inflammatory Bowel Disease.

Authors:  De-Feng Li; Mei-Feng Yang; Jing Xu; Hao-Ming Xu; Min-Zheng Zhu; Yu-Jie Liang; Yuan Zhang; Cheng-Mei Tian; Yu-Qiang Nie; Rui-Yue Shi; Li-Sheng Wang; Jun Yao
Journal:  Int J Nanomedicine       Date:  2022-09-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.